A new program explores the possibility of treating Alzheimer's disease using precision medicine. What is Accelerating Medicines Partnership Alzheimer's disease program (AMP AD 2.0), and where is research advancing?
Insights into a recently published comprehensive review in Cancer Reports. The review, featuring Icahn School of Medicine at Mount Sinai researchers, discusses the implications of using precision medicine to treat prostate cancer in different populations, particularly African American men.
This research provides new findings on how the scope of genetic testing programs should be expanded, answers what is Watershed.
As COVID-19 research grows, new emphasis on potential individualized treatment options offers promising application of precision medicine The COVID-19 pandemic's unprecedented force of change on traditional medical device and therapeutics development has brought fresh perspectives and new opportunities for precision medicine partnerships. With COVID-19, precision medicine focuses on better understanding of how and why the …
Precision medicine is demonstrating its potential value in the face of a second wave of coronavirus outbreak
Stratifying cancer patients switched from adjuvant chemotherapy to targeted treatments during the coronavirus pandemic
Understand the affiliations and implications of the CDC’s new SPHERES initiative for rapid SARS-CoV-2 genome sequencing.
Why gene editing technology CRISPR is getting attention as a potential testing solution amid the coronavirus pandemic.
"Don't underestimate the importance of aligning the interests of different stakeholders," says the CTO of the Danish National Genome Center. Here are his tips for getting alignment on shared goals.
The need to build up critical mass quickly may tempt hospital and health system leaders to cut corners when it comes to being forthcoming with patients. Don’t fall into that trap...